Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mecasermin rinfabate by Chiesi Farmaceutici for Bronchopulmonary Dysplasia: Likelihood of Approval
Mecasermin rinfabate is under clinical development by Chiesi Farmaceutici and currently in Phase II for Bronchopulmonary Dysplasia. According to GlobalData,...
Data Insights
Mecasermin rinfabate by Oak Hill Bio for Hemorrhage: Likelihood of Approval
Mecasermin rinfabate is under clinical development by Oak Hill Bio and currently in Phase II for Hemorrhage. According to GlobalData,...